Latest round: Growth. John Bencich is the CEO of Achieve Life Sciences, a late-stage specialty pharmaceutical company focused on developing therapies.
John Bencich is the CEO of Achieve Life Sciences, a late-stage specialty pharmaceutical company focused on developing therapies for nicotine dependence and smoking cessation. He has overseen the initiation of Phase 3 trials for the company's smoking cessation candidate, cytisinicline.
Full founder directory · Investor directory · Company funding database · Fundraising library